Evidence map›Paper›PMID 41588682›Full record

ArticleMicroscopy research and technique2026

In Vitro Evaluation of Novel Calcium Silicate-Based and Resin-Modified Calcium Silicate Materials: Cytocompatibility and Mineralization Potential on Human Dental Pulp Stem Cells for Pulp Repair.

Francisco Javier Rodríguez-Lozano, Nuria Pérez-Guzmán, Paula García-Rios, David García-Bernal, Adrián Lozano, Sergio López-García

Abstract read
In one paragraph

Article in Microscopy research and technique, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Francisco Javier Rodríguez-LozanoDepartment of Dermatology, Stomatology, Radiology and Physical Medicine, Morales Meseguer Hospital, Faculty of Medicine, IMIB-Arrixaca, University of Murcia, Murcia, Spain.
Nuria Pérez-GuzmánDepartment of Dermatology, Stomatology, Radiology and Physical Medicine, Morales Meseguer Hospital, Faculty of Medicine, IMIB-Arrixaca, University of Murcia, Murcia, Spain.
Paula García-RiosDepartment of Dermatology, Stomatology, Radiology and Physical Medicine, Morales Meseguer Hospital, Faculty of Medicine, IMIB-Arrixaca, University of Murcia, Murcia, Spain.
David García-BernalDepartment of Biochemistry, Molecular Biology B and Immunology, Faculty of Medicine, University of Murcia, Biomedical Research Institute (IMIB), Murcia, Spain.
Adrián LozanoDepartament D'estomatologia, Facultat De Medicina I Odontologia, Universitat De València, Valencia, Spain.
Sergio López-GarcíaDepartment of Dermatology, Stomatology, Radiology and Physical Medicine, Morales Meseguer Hospital, Faculty of Medicine, IMIB-Arrixaca, University of Murcia, Murcia, Spain.

Funding

Fundación Séneca FSRM/10.13039/100007801(22629/PI/24)Instituto de Salud Carlos III RD24/0014/0040
6 · The paper itself

Abstract

This study aimed to evaluate the biological effects of three calcium silicate-based materials-Biodentine XP (BD-XP), TheraCal PT (THPT), and TheraBase Ca (THB)-on human dental pulp stem cells (hDPSCs), focusing on cytocompatibility, immunomodulatory behavior (via IL-6 expression), and odontogenic/mineralization potential compared to control conditions. hDPSCs were cultured with eluates (25%, 50%, 100%) of BD-XP, THPT, and THB. Cytocompatibility was assessed via metabolic activity assay, cell cycle analysis, and cell migration. Morphology and adhesion were examined by SEM, while surface composition was analyzed by EDX. IL-6 secretion was quantified using ELISA. Gene expression of odontogenic/osteogenic markers (ALP, DSPP, RUNX2, COL-1) was analyzed via qRT-PCR at 14 and 21 days. Alizarin Red S staining was used to assess mineralization. Results were compared to unconditioned and osteogenic controls (p < 0.05). All materials exhibited acceptable cytocompatibility. BD-XP promoted the highest cell viability, migration, and adhesion. IL-6 secretion was significantly reduced in all treated groups, most notably with THB. SEM and EDX showed strong cell attachment and calcium-rich surfaces for BD-XP. BD-XP significantly upregulated DSPP and RUNX2 at both time points and COL-1 at day 21. ALP expression was mainly observed in the positive control. BD-XP also showed the greatest mineralized nodule formation. Biodentine XP demonstrated the most favorable biological behavior, showing high cytocompatibility, upregulation of odontogenic markers, and enhanced mineralization. These results highlight its potential for clinical use in vital pulp therapy and regenerative endodontics.

Indexed as

Biocompatible MaterialsCalcium CompoundsDental PulpSilicatesStem CellsCalcification, PhysiologicCell AdhesionCell DifferentiationCell MovementCells, CulturedCell SurvivalHumansInterleukin-6OsteogenesisBiocompatible MaterialsCalcium Compoundscalcium silicateInterleukin-6Silicatescalcium silicate‐based materialsdental pulp reparationvital pulp materials

Identifiers

PMID41588682
PMCPMC13134820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.